These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16571891)

  • 1. Infliximab for ulcerative colitis.
    Shields CJ; Winter DC
    N Engl J Med; 2006 Mar; 354(13):1424-6; author reply 1424-6. PubMed ID: 16571891
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab for ulcerative colitis.
    Becker JM; Prushik SG; Stucchi AF
    N Engl J Med; 2006 Mar; 354(13):1424-6; author reply 1424-6. PubMed ID: 16575950
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.
    Su C; Salzberg BA; Lewis JD; Deren JJ; Kornbluth A; Katzka DA; Stein RB; Adler DR; Lichtenstein GR
    Am J Gastroenterol; 2002 Oct; 97(10):2577-84. PubMed ID: 12385442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of steroid-dependent ulcerative colitis: immunomodulatory agents, biologics, or surgery?
    Velayos F; Mahadevan U
    Clin Gastroenterol Hepatol; 2007 Jun; 5(6):668-71. PubMed ID: 17544992
    [No Abstract]   [Full Text] [Related]  

  • 5. Infliximab for ulcerative colitis: the need for adequately powered placebo-controlled trials.
    Rutgeerts P
    Am J Gastroenterol; 2002 Oct; 97(10):2488-9. PubMed ID: 12385428
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab.
    Hassan C; Ierardi E; Burattini O; De Francesco V; Zullo A; Stoppino G; Panella C; Morini S
    Dig Liver Dis; 2007 Sep; 39(9):811-7. PubMed ID: 17652038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab for refractory ulcerative colitis.
    Chey WY; Hussain A; Ryan C; Potter GD; Shah A
    Am J Gastroenterol; 2001 Aug; 96(8):2373-81. PubMed ID: 11513177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal vein thrombosis following infliximab treatment for severe left-sided ulcerative colitis.
    Veerappan SG; Kennedy M; O'Morain CA; Ryan BM
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):588-9. PubMed ID: 18467922
    [No Abstract]   [Full Text] [Related]  

  • 10. [Severe ulcerative colitis, with toxic megacolon, resolved with infliximab therapy].
    Castro Fernández M; García Romero D; Sánchez Muñoz D; Grande L; Larraona JL
    Rev Esp Enferm Dig; 2007 Jul; 99(7):426-7. PubMed ID: 17973593
    [No Abstract]   [Full Text] [Related]  

  • 11. TNF-alpha gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative colitis.
    Olsen T; Goll R; Cui G; Christiansen I; Florholmen J
    Cytokine; 2009 May; 46(2):222-7. PubMed ID: 19286392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of manic switch by the tumour necrosis factor-alpha antagonist infliximab.
    Elisa B; Beny L
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):442-3. PubMed ID: 20653912
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of the anti-tumour necrosis factor monoclonal antibody--infliximab--to treat ulcerative colitis: implications and trends beyond the available data.
    Rossetti S; Actis GC; Fadda M; Rizzetto M; Palmo A
    Dig Liver Dis; 2004 Jun; 36(6):426-31. PubMed ID: 15248385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab for ulcerative colitis.
    Reinshagen M
    N Engl J Med; 2006 Mar; 354(13):1424-6; author reply 1424-6. PubMed ID: 16575949
    [No Abstract]   [Full Text] [Related]  

  • 15. [Infliximab treatment of peristomal pyoderma gangrenosum in ulcerative colitis].
    Nybaek H; Jemec GB
    Ugeskr Laeger; 2005 Aug; 167(32):2920-1. PubMed ID: 16109221
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab for ulcerative colitis following liver transplantation.
    Lal S; Steinhart AH
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):277-80. PubMed ID: 17301656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open-label infliximab therapy in ulcerative colitis: a multicenter survey of results and predictors of response.
    Gonzalez-Lama Y; Fernandez-Blanco I; Lopez-SanRoman A; Taxonera C; Casis B; Tabernero S; Bermejo F; Martinez-Silva F; Mendoza JL; Martinez-Montiel P; Carneros JA; Sanchez F; Maté J; Gisbert JP;
    Hepatogastroenterology; 2008; 55(86-87):1609-14. PubMed ID: 19102352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis technique confirms the effectiveness of anti-TNF-alpha in the management of active ulcerative colitis when administered in combination with corticosteroids.
    Rahimi R; Nikfar S; Abdollahi M
    Med Sci Monit; 2007 Jul; 13(7):PI13-8. PubMed ID: 17599035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor necrosis factor therapy for ulcerative colitis.
    Kountouras J; Zavos C; Chatzopoulos D
    Gastroenterology; 2005 Sep; 129(3):1138-9. PubMed ID: 16143158
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula.
    Hassan C; Zullo A; Ierardi E; Burattini O; De Francesco V; Morini S
    Gut; 2006 Apr; 55(4):589-90. PubMed ID: 16531548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.